Boston Business Journal: Reverberations of the Shutdown Felt by MA Businesses

This month, Back Bay CEO, Jonathan P. Gertler, MD, spoke with the Boston Business Journal about the effects on Massachusetts businesses of the federal government's ongoing partial shutdown. Along with far-reaching impact, here in the Baystate, the shutdown is halting or slowing many of the processes area businesses rely upon, “such as those handled by agencies like the Securities and Exchange Commission, the Internal Revenue Service or the Food and Drug Administration,” reports the BBJ.“The slowdown at the FDA has already had an effect at one of the biotech and pharmaceutical industry's largest events last week, the JP Morgan Health Care Conference. Back Bay Life Science Advisors CEO Jonathan Gertler said that executives he knows had a hard time pitching to and updating investors during the event because they hadn't been able to get feedback about their clinical trial plans from the FDA.

‘There will be a snowball, cascade effect on the way. It will affect companies' ability to move forward with products," Gertler told the Business Journal.’”

Related links:

Boston Business Journal - Reverberations of the gov't shutdown felt by Mass. businesses